Simon Walker-Samuel

University College London

Simon undertook a PhD and then post-doctoral fellowship at the Institute of Cancer Research, developing novel imaging biomarkers for assessing the response of tumours to anticancer therapies with magnetic resonance imaging (MRI). Following a move to the Centre for Advanced Biomedical Imaging at University College London, he was awarded a Wellcome Trust Senior Research Fellowship in 2013 to develop MRI techniques to assess tumour microstructure and predict drug delivery, using machine learning.

dont miss

Using medical imaging with machine learning to develop efficient tools for diagnosing cancer

This seminar will describe new approaches for assessing tumour microstructure with MRI, using machine learning / artificial intelligence techniques.

Simon Walker-Samuel will be speaking in the following theatre:

Theatre 9 - Wednesday 14.00 - 14.30: Using medical imaging with machine learning to develop efficient tools for diagnosing cancer

EVEN MORE SEMINARS

  • Simon Walker-Samuel: Speaking at the Medical Imaging Convention

    Simon Walker-Samuel
    University College London

    Using medical imaging with machine learning to develop efficient tools for diagnosing cancer

  • Sue Edyvean: Speaking at the Medical Imaging Convention

    Sue Edyvean
    Public Health England

    National Diagnostic Reference Levels for patient radiation dose – current status, future plans, and how to contribute

  • Andy Rogers – Lead Interventional MPE: Speaking at the Medical Imaging Convention

    Andy Rogers – Lead Interventional MPE
    Nottingham University Hospitals NHS Trust

    Integrating interventional procedure data to improve clinician feedback – new technology gains maturity

  • Laura Shell: Speaking at the Medical Imaging Convention

    Laura Shell
    University Hospital Birmingham (HGS)

    The Impact of Computerised Tomography Standardisation in the UK

  • Wai Lup Wong: Speaking at the Medical Imaging Convention

    Wai Lup Wong
    Mount Vernon Hospital, Northwood

    PET CT in the Surveillance of People with Head and Neck Cancer